CD38 is a potential treatment target in lymphoma patients concurrently infected with human immunodeficiency virus

Trine Engelbrecht Hybel; Maja Ølholm Vase; Kristina Lystlund Lauridsen; Marie Beck Enemark; Michael Boe Møller; Court Pedersen; Gitte Pedersen; Stephen Hamilton-Dutoit; Niels Obel; Carsten Schade Larsen; Francesco d’Amore; Maja Ludvigsen

doi:10.1080/10428194.2021.2023741

CD38 is a potential treatment target in lymphoma patients concurrently infected with human immunodeficiency virus

Trine Engelbrecht Hybel, Maja Ølholm Vase, Kristina Lystlund Lauridsen, Marie Beck Enemark, Michael Boe Møller, Court Pedersen, Gitte Pedersen, Stephen Hamilton-Dutoit, Niels Obel, Carsten Schade Larsen, Francesco d’Amore, Maja Ludvigsen^*

^*Corresponding author for this work

Research output: Contribution to journal › Journal article › Research › peer-review

Original language	English
Journal	Leukemia and Lymphoma
Volume	63
Issue number	6
Pages (from-to)	1479-1483
ISSN	1042-8194
DOIs	https://doi.org/10.1080/10428194.2021.2023741
Publication status	Published - Jun 2022

Documents & Links

10.1080/10428194.2021.2023741

Cite this

Hybel, T. E., Vase, M. Ø., Lauridsen, K. L., Enemark, M. B., Møller, M. B., Pedersen, C., Pedersen, G., Hamilton-Dutoit, S., Obel, N., Schade Larsen, C., d’Amore, F., & Ludvigsen, M. (2022). CD38 is a potential treatment target in lymphoma patients concurrently infected with human immunodeficiency virus. Leukemia and Lymphoma, 63(6), 1479-1483. https://doi.org/10.1080/10428194.2021.2023741

@article{a5d829cf943e4f57b345531b56f5e46a,

title = "CD38 is a potential treatment target in lymphoma patients concurrently infected with human immunodeficiency virus",

author = "Hybel, {Trine Engelbrecht} and Vase, {Maja {\O}lholm} and Lauridsen, {Kristina Lystlund} and Enemark, {Marie Beck} and M{\o}ller, {Michael Boe} and Court Pedersen and Gitte Pedersen and Stephen Hamilton-Dutoit and Niels Obel and {Schade Larsen}, Carsten and Francesco d{\textquoteright}Amore and Maja Ludvigsen",

year = "2022",

month = jun,

doi = "10.1080/10428194.2021.2023741",

language = "English",

volume = "63",

pages = "1479--1483",

journal = "Leukemia and Lymphoma",

issn = "1042-8194",

publisher = "Taylor & Francis",

number = "6",

}

Hybel, TE, Vase, MØ, Lauridsen, KL, Enemark, MB, Møller, MB , Pedersen, C, Pedersen, G, Hamilton-Dutoit, S, Obel, N, Schade Larsen, C, d’Amore, F & Ludvigsen, M 2022, 'CD38 is a potential treatment target in lymphoma patients concurrently infected with human immunodeficiency virus', Leukemia and Lymphoma, vol. 63, no. 6, pp. 1479-1483. https://doi.org/10.1080/10428194.2021.2023741

TY - JOUR

T1 - CD38 is a potential treatment target in lymphoma patients concurrently infected with human immunodeficiency virus

AU - Hybel, Trine Engelbrecht

AU - Vase, Maja Ølholm

AU - Lauridsen, Kristina Lystlund

AU - Enemark, Marie Beck

AU - Møller, Michael Boe

AU - Pedersen, Court

AU - Pedersen, Gitte

AU - Hamilton-Dutoit, Stephen

AU - Obel, Niels

AU - Schade Larsen, Carsten

AU - d’Amore, Francesco

AU - Ludvigsen, Maja

PY - 2022/6

Y1 - 2022/6

U2 - 10.1080/10428194.2021.2023741

DO - 10.1080/10428194.2021.2023741

M3 - Journal article

C2 - 35019824

AN - SCOPUS:85122825283

SN - 1042-8194

VL - 63

SP - 1479

EP - 1483

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

IS - 6

ER -